510(k) device
Levo Gen 2 Tinnitus Therapy System
Levo Medical Corporation · Masker, Tinnitus (KLW, Class II) · First FDA decision Aug 13, 2026, newest Aug 13, 2026Tinnitus
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
1
510(k) pathway
Device trials
593
Naming "Gen 2"
MAUDE reports
943
Brand "Gen 2", since 2015
PubMed studies
124
Mentioning "Gen 2"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Levo Gen 2 Tinnitus Therapy System
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 1 of 1 decisions filed under this name.
K260413 · Decided Aug 13, 2026 · 185 days after receipt
Device type: Masker, Tinnitus (KLW) · Otolaryngology (ENT)
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "Gen 2", any status and sponsor, newest update first.
- Reducing Exposure With Air Cleaners and TechnologyPivotal-lookingRecruiting
University of California, BerkeleyAcademic, hospital or other
NCT07914010 · 100 participants (planned) · Start Nov 17, 2026 · Primary completion Sep 2027
Device: Air Cleaner; PM2.5 Monitor with Visual Air Quality Indicator · For: Asthma; COPD (Chronic Obstructive Pulmonary Disease)
Sites: Berkeley, California; San Francisco, California · 3 sites in all
- High-flow Nasal Oxygenation in Obese Patients During Colonoscopy: a Randomized Controlled Trial (COCOON)Pivotal-lookingNot yet recruiting
Assistance Publique - Hôpitaux de ParisAcademic, hospital or other
NCT07947160 · 100 participants (planned) · Start Jan 1, 2027 · Primary completion Jul 1, 2028
Device: Conventional oxygen therapy (oxygen capnography mask); High-flow nasal oxygen therapy (Optiflow®) · For: Obesity (BMI>30)
Sites: Clichy, France; Colombes, France; Paris, France
- AIRE-2 Device for Study of Breath Analysis in IBDActive, not recruiting
McMaster UniversityAcademic, hospital or other
NCT06541938 · 57 participants · Start Aug 28, 2024 · Primary completion Nov 2, 2026
Device: AIRE-2 Portable breath analyzer · For: Inflammatory Bowel Diseases
Sites: Hamilton, Canada
590 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Gen 2", and for the whole product code for context.
This brand
943 reports: 885 malfunction, 33 injury, 25 death
Whole product code KLW
4 reports: 1 malfunction, 3 injury, 0 death
Newest reports for this brand
- Magnesium Gen.2Malfunction
1823260-2026-04416 · Received Oct 23, 2026 · Event dated Sep 28, 2026
Device type: Photometric Method, Magnesium (JGJ)
Device problem as coded: Non Reproducible Results
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
- Tina-quant Albumin Gen.2 - Urine ApplicationMalfunction
1823260-2026-04420 · Received Oct 23, 2026 · Event dated Oct 2, 2026
Device type: Albumin, Antigen, Antiserum, Control (DCF)
Device problem as coded: High Test Results
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
- PC Gen 2, Non-QSK, Sterile, JapanMalfunction
1220648-2026-13845 · Received Oct 22, 2026 · Event dated Oct 6, 2026
Device type: Temporary Non-Roller Type Left Heart Support Blood Pump (OZD)
Device problem as coded: Priming Problem
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
2 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "Gen 2"[tiab]. The summary above synthesizes these.
- Targeted in vivo delivery of genetic medicines utilizing an engineered lentiviral vector platform results in CAR T and NK cell generation.
Andorko JI, Russell RM, Schnepp BC, et al. · Mol Ther · 2025Research Support, Non-U.S. Gov't
- Integration of AI-Generated Images in Clinical Otolaryngology.
Javan R, Cole J, Hsiao S, et al. · Cureus · 2024Editorial
- Expanding the human gut microbiome atlas of Africa.
Maghini DG, Oduaran OH, Olubayo LAI, et al. · Nature · 2025Research Support, N.I.H., Extramural
- Untargeted Metabolomic Profiling of Extracellular Vesicles Isolated from Human Seminal Plasma.
Panner Selvam MK, Chandra PK, Bakhtiary Z, et al. · Biomolecules · 2024Research Support, Non-U.S. Gov't, Research Support, N.I.H., Extramural
- Expanding the human gut microbiome atlas of Africa.
Maghini DG, Oduaran OH, Wirbel J, et al. · bioRxiv · 2024Preprint
- Gen-2 hand-held optical imager towards cancer imaging: reflectance and transillumination phantom studies.
Gonzalez J, Roman M, Hall M, et al. · Sensors (Basel) · 2012Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't
- Generation and Characterization of Ex Vivo Expanded Tumor-infiltrating Lymphocytes From Renal Cell Carcinoma Tumors for Adoptive Cell Therapy.
Einstein DJ, Halbert B, Denize T, et al. · J Immunother · 2024Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't
- Genetic parameters for egg quality traits in Pekin ducks.
Kroger CA, Lee W, Fraley GS, et al. · Poult Sci · 2024
- Comparison of EEG Signal Spectral Characteristics Obtained with Consumer- and Research-Grade Devices.
Mikhaylov D, Saeed M, Husain Alhosani M, et al. · Sensors (Basel) · 2024Comparative Study
- The multi-mode acoustic gravitational wave experiment: MAGE.
Campbell WM, Goryachev M, Tobar ME · Sci Rep · 2023
- Innovative Orthodontic-Restorative Treatment With Customized CAD/CAM Smartwires.
Weissheimer A, Kravitz ND, Pham J, et al. · J Esthet Restor Dent · 2025Case Reports
- Attenuation of accelerated renal cystogenesis in Pkd1 mice by renin-angiotensin system blockade.
Fitzgibbon WR, Dang Y, Bunni MA, et al. · Am J Physiol Renal Physiol · 2018Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't
Other devices of this type
Also filed under product code KLW.
- Tinnitus Sound Generator ModuleGN Hearing A/S · 510(k) 2020
- Tinnitus Sound Generator ModuleGn Resound A/S · 510(k) 2015
- Multiflex Tinnitus TechnologyStarkey Laboratories, Inc. · 510(k) 2020
- SoundCure Serenade Tinnitus Treatment SystemSoundcure, Inc. · 510(k) 2015
- Tinnitus TherapySivantos GmbH · 510(k) 2026
- Peace N Quiet (0.7.0)Pnq Health · 510(k) 2024
- Tinearity G1 (6103)Duearity AB · 510(k) 2023
- Tinnitogram Signal GeneratorGoldenear Company, Inc. · 510(k) 2023
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.